Legal
Purdue Pharma Wins Short Window to Negotiate New Sackler Deal
- Purdue creditors are attempting to negotiate a new settlement
- Judge said litigation pause is needed to facilitate deal talks
Lawyers for opioid victims indicated Tuesday they’re prepared to sue the Sacklers if negotiations don’t result in a new deal.
Photographer: George Frey/Bloomberg
Purdue Pharma LP secured a two-month window to negotiate a new pact with members of the Sackler family as the OyxContin maker and its owners brace for a potential wave of civil opioid lawsuits after the US Supreme Court scuttled an earlier $6 billion settlement.
Judge Sean Lane said during a Tuesday court hearing in New York that he’d extend for 60 days an injunction that, for years, has paused opioid litigation against the billionaire family while Purdue, government authorities and victims lawyers attempted to effectuate the earlier settlement.